Jaguar Health, Inc

Jaguar Health, Inc. (NASDAQ: JAGX) is a commercial-stage pharmaceutical company. The Company is focused on developing plant-based, sustainably derived prescription medicines for people and animals with gastrointestinal (GI) distress, including chronic and debilitating diarrhea. It operates through two segments: human health and animal health.

­­­­Recent Business Updates:

• On May 10, Nasdaq notified the company of a potential delisting or failure to meet a continued listing rule or standard.
• In the first quarter of 2023, the company experienced a decrease in net revenue compared to the same period in 2022. However, there was an improvement in net loss during that time.
• Jaguar has made an agreement not to issue any additional equity securities until October 22, 2023. By that time, the company anticipates releasing top-line data for the Phase 3 OnTarget trial.
• Noteworthy achievements include the completion of enrollment for the Phase 3 OnTarget trial and the planned submission of an Investigational New Drug (IND) application to the FDA for crofelemer for the treatment of microvillus inclusion disease in the second quarter of 2023.

Technical Observation (on the daily chart)

With a past year correction of almost 97.64%, the price has been in a persistent downward trend over the last year, with the medium-term also a downward trend evident by only 96.76% correction in previous six months. The price has taken rejection from an important resistance zone of USD 1.20-SUSD 1.4, from where a reversal has happened, with the most recent support around USD 0.65 levels. Also, the momentum indicator RSI (14 period) displays a value of 49.83, indicating some consolidation or some further correction. Price is currently between the 21-day SMA and 50-day SMA trend-following indicators, which can serve as dynamic short-term support and resistance respectively.   

As per the above-mentioned price action, volatility in the stock, low market capitalisation, recent financial results, NASDAQ potential delisting notification, and technical indicators analysis, an ‘Avoid’ rating has been given Jaguar Health, Inc. at the current price of current price of USD 0.75, as of May 15, 2023, at 08:15 am PDT.

Individuals can evaluate the stock based on the support and resistance levels provided in the report in case of keen interest taking into consideration the risk-reward scenario. 

Markets are trading in a highly volatile zone currently due to certain macro-economic issues and prevailing geopolitical tensions. Therefore, it is prudent to follow a cautious approach while investing. 

Related Risk: This report may be looked at from a high-risk perspective and a recommendation is provided for a short duration. This report is solely based on technical parameters, and the fundamental performance of the stocks has not been considered in the decision-making process. Other factors which could impact the stock prices include market risks, regulatory risks, interest rates risks, currency risks, social and political instability risks etc. 

How to Read the Charts?

The Green colour line reflects the 21-period simple moving average (SMA) while the red line indicates the 50- period simple moving average (SMA). SMA helps to identify existing price trends. If the prices are trading above the 21-period and 50-period moving average, then it shows prices are currently trading in a bullish trend.

The Black colour line in the chart’s lower segment reflects the Relative Strength Index (14-Period) which indicates price momentum and signals momentum in trend. A reading of 70 or above suggests overbought status while a reading of 30 or below suggests an oversold status.

The Blue colour bars in the chart’s lower segment show the volume of the stock. The volume is the number of shares that changed hands during a given day. Stocks with high volumes are more liquid than stocks with lesser volume as liquidity in stocks helps in easier and faster execution of the order.

The Orange colour lines are the trend lines drawn by connecting two or more price points and used for trend identification purposes. The trend line also acts as a line of support and resistance.

Technical Indicators Defined: -

Support: A level at which the stock prices tend to find support if they are falling, and a downtrend may take a pause backed by demand or buying interest. Support 1 refers to the nearby support level for the stock and if the price breaches the level, then Support 2 may act as the crucial support level for the stock. 

Resistance: A level at which the stock prices tend to find resistance when they are rising, and an uptrend may take a pause due to profit booking or selling interest. Resistance 1 refers to the nearby resistance level for the stock and if the price surpasses the level, then Resistance 2 may act as the crucial resistance level for the stock. 

Stop-loss: It is a level to protect further losses in case of unfavourable movement in the stock prices. 

The reference date for all price data, currency, technical indicators, support, and resistance levels is May 15, 2023. The reference data in this report has been partly sourced from REFINITIV. 

Abbreviations

CMP: Current Market Price

SMA: Simple Moving Average

RSI: Relative Strength Index

USD: United States dollar 

Note: Trading decisions require a thorough analysis by individual. Technical reports in general chart out metrics that may be assessed by individuals before any stock evaluation. The above are illustrative analytical factors used for evaluating the stocks; other parameters can be looked at along with additional risks per se. Past performance is neither an indicator nor a guarantee of future performance.